Cancer Research UK logo.
SearchDonate
  • Search

A trial of tazemetostat for diffuse large B cell lymphoma and follicular lymphoma

Overview

Cancer types:

Blood cancers, High grade lymphoma, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 1/2

Details

This trial is for people with diffuse large B cell lymphoma or follicular lymphoma that has come back after or continued to get worse during treatment.

The trial is now only open to people with follicular lymphoma. There are enough people with diffuse large B cell lymphoma taking part in the trial.

Recruitment start: 1 January 2013

Recruitment end: 10 June 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Peter Johnson

Supported by

Epizyme, Inc.

Experimental Cancer Medicines Centres (ECMC)

NIHR Clinical Research Network: Cancer

Last reviewed: 12 Jun 2019

CRUK internal database number: 13512

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.